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Abstract. Alphaviruses (Togaviridae, Alphavirus) are arthropod-borne single-stranded RNA pathogens that cause
febrile and neurologic disease in much of Latin America. However, many features of Alphavirus epidemiology remain
unknown. In 2011, we undertook a cross-sectional study in Nueva Esperanza, an indigenous community in the Peruvian
Amazon. Here, we present the first serologic evidence of Mayaro (MAYV), Venezuelan equine encephalitis (VEE) complex
alphavirus, Una (UNAV), and Madariaga (MADV) viruses reported in humans (24%, 16%, 13%, and 1.5%, respectively)
fromanAmazonian indigenous community inPeru. Hunting activity andcohabitingwith hunterswere themain risk factors
forMayaro seroconversion, but only huntingwasassociatedwithUNAVseropositivity.Our results suggest that alphavirus
infection in this region is common, but we highlight the high UNAV seroprevalence found and corroborate the lowMADV
prevalence reported in this region. Furthermore,MAYV-neutralizing antibodieswere also detected in stored samples from
wild animals (18%) hunted by Nueva Esperanza inhabitants and another mestizo community located close to Iquitos.
Further serological surveys of VEE complex alphaviruses, UNAV, and MADV in wild animals and assessing the ability of
the MAYV seropositive species to transmit the virus will be relevant.
INTRODUCTION
Arthropod-borne zoonotic alphaviruses (Togaviridae,
Alphavirus) are positive-sense single-strand RNA viruses
that are recognized as an important cause of acute febrile
illness in humans in Latin America. In the Peruvian Amazon,
Mayaro virus (MAYV) accounts for nearly 1% of outpatient
evaluations for febrile disease,1 and cases have been re-
ported in Latin American countries as well as in travelers
returning from the Amazon Basin.2,3 Venezuelan equine
encephalitis (VEE) complex alphaviruses, such as VEE virus
(VEEV), have caused outbreak within the urban areas of
Iquitos, the largest city in the Peruvian Amazon, but few
neurological cases and deaths have been observed.4,5 Less
is known about Madariaga virus (MADV) infection in this
region. Despite the enzootic circulation and intensive sur-
veillance, only few seropositive individuals and no neuro-
logic disease or fatal cases have been reported.6 However,
encephalitis cases and mild or asymptomatic cases mostly
affecting children have been attributed to MADV recently in
Venezuela, Haiti, and Panama.7–10 Finally, although Una
virus (UNAV) has been isolated from mosquitos of the
Peruvian Amazon, it has been rarely associated with human
disease.11,12 Therefore, its distribution and the human dis-
ease risk in this region remain unknown.
Although these alphaviruses are a well-recognized cause
of human disease in the Americas, prior research studies
were only carried out in the peri-urban area of Iquitos. An
important reason behind this is the challenge of conducting
research in Amazonian communities because of different
barriers (e.g., geographical, sociocultural, and health ser-
vice access).13 The lack of surveillance studies in in-
digenous communities and the identification of potential
wildlife hosts in the Amazon highlight the importance of
studying this region. Furthermore, the continuous ecologi-
cal disturbance in the Amazon rainforest through human
activities such as hunting, logging, and ecotourism may be
significant risk factors for infection with these viruses.4,14
Therefore, we sought to investigate the epidemiology of
these viruses through a cross-sectional serosurvey, in-
volving humans and wildlife, in an indigenous community of
the Peruvian Amazon.
MATERIALS AND METHODS
Human and animal survey. This study was conducted in
Nueva Esperanza (S 0419.53 W 7157.33), 302 km northeast
from Iquitos (Figure 1). This is an indigenous community of 297
inhabitants, whose main occupations are small-scale agri-
culture, fishing, logging, and subsistence hunting. In 2011, we
collected human serum samples from 70 volunteers (ranged
from age 5 to 81 years) of this community. Between 2007 and
2008, we also collected blood samples from 90 wild animals
harvested by local hunters from Nueva Esperanza and Sol
Naciente (S 0338.26 W 7312.57), a mestizo community lo-
cated 26 km from Iquitos where agricultural land use has
partially replaced the forest.
Laboratory testing. Human samples were first tested by
plaque reduction neutralization tests (PRNT) against MAYV
(strain TRVL15537), MADV (chimeric SIN/MADV derived from
Brazilian MADV strain BeAn436087), and VEE complex
alphavirus (vaccine strain TC-83).15,16 All samples with
PRNT80 titers ³ 20 were considered positive. To complement
PRNT results and as a secondary goal because of the low
serum volume available, the leftover sample was tested in
triplicate for IgG antibodies to antigens of MAYV, MADV, and
VEE complex viruses. We used a capture ELISA.17 For the
ELISA, the TRVL15537 strain was used for MAYV and
sucrose-acetone antigens were prepared from MADV- (pre-
pared by Dr. Robert Shope at the Yale Arbovirus Research
Unit in August 1989), and VEE complex alphaviruses (vaccine
strain TC-83 andMosso dasPedras 78V3531) infectedmouse
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brain (provided by the US CDC and University of Texas
Medical Branch (UTMB)World ReferenceCenter for Emerging
Viruses and Arboviruses, respectively). To discriminate MAYV
positives from cross-reactivity with UNAV, the leftover from all
the samples was first screened in 1:20 dilution of the UNAV
strain BT-1495-3 and then tested by PRNT80. Chikungunya
virus was not tested because these samples were collected in
2011, before chikungunya virus circulated in the Americas.
Wild animal samples were tested only by PRNT against
MAYV (strain TRVL15537). Plaque reduction neutralization
tests for VEE complex alphaviruses, MADV, and UNAV could
not be performed because of insufficient samples.
Statistical analysis. We used a recursive modeling ap-
proach with classification trees to identify major risk factors
linked to the presence of antibodies against these alphavi-
ruses using the package “rpart” version 4.1–13 of the statis-
tical software R version 3.4.2.18,19 Risk factors evaluated for
prior human infection were gender, hunting activity, logging
activity, and cohabitation with seropositive people. Model
simplification takes into consideration the complexity pa-
rameter of the tree showing the minimum relative error after
10-fold cross-validations.
Ethics. Research protocols were approved by the Peruvian
Forestry and Wildlife Agency (041-2007-DGFFS), the In-
stitutional Animal Care and Use Committee of U.S. Naval
Medical Research Unit No. 6, and Instituto Nacional de Salud
del Perú (#08-982).
RESULTS
Characteristics of the human population. A total of 70
participants (23.6% of local inhabitants) who belong to 22
houses (48.9%of total houses) were surveyed. The age range
was 5–81 years, with a median age of 20 (Q1 = 10 and Q3 =
34.5). The proportion of females was 58.8%. A total of 18.6%
of participants declared to hunt, whereas 14.3% declared to
participate in logging activities. The total number of persons
per house ranged between one and seven (Table 1).
Human seroprevalence. Based on our PRNT results, the
seroprevalence for MAYV, VEE complex alphavirus, UNAV,
and MADV in people from Nueva Esperanza was 24% (17/70,
95%CI [16–35]), 16% (11/67, 95%CI [9–27]), 13% (6/48, 95%
CI [6–25]), and 1.5% (1/67, 95% CI [0–8]), respectively
(Supplemental Table 1). For MAYV, the most parsimonious
tree model explained 27% of likelihood of showing antibodies
against MAYV, including two risk factors: hunting activity and
cohabitation with seropositive people (Figure 2). This means
that being a hunter (75%, 95%CI [42.81–94.51]) or not being a
hunter but sharing home with MAYV seropositive people
(21%, 95%CI [9.5–37.3]) were the main risk factor associated
with MAYV circulation. Individuals who were nonhunters and
not living in a seropositive household were seronegative. The
UNAV treemodel also showedhunting activity as themain risk
factor (80%, 95% CI [28.4–99.5]) for the virus infection,
explaining 49% of the observed UNAV seropositive variability.
FIGURE 1. Nueva Esperanza and Sol Naciente communities in the Department of Loreto, Peru. This figure appears in color at www.ajtmh.org.
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People who did not report hunting had a lower UNAV sero-
prevalence of 4–7% (95% CI [0.6–16.2]). No other variables
were associated. Una virus seropositiveswere also exposed to
MAYV or other alphavirus, but some individuals only showed
exposure to UNAV. Despite the high seroprevalence (16%) of
VEE complex virus, the tree models showed that none of the
studiedvariableswere related to thepositivecases.Risk factors
to MADV infection were not evaluated because of concerns
about the representativeness of the sample because only one
sample was found seropositive.
Animal seroprevalence. Anti–MAYV-neutralizing anti-
bodieswere detected inwild animals (18%, 95%CI [11–27%])
collected near Nueva Esperanza and Sol Naciente commu-
nities. The highest MAYV seroprevalence in wild animals was
observed in armadillos (40%), followed by nonhuman pri-
mates (33%), peccaries (11%), and rodents (10%) (Table 2).
DISCUSSION
Recent epidemiological and surveillance studies have
shown that human alphavirus infections in Latin America are
common.2,16,20 Herein, we demonstrate endemic infection
with new world alphaviruses in the Amazon region of Peru. In
addition, we provide serologic results of potential wildlife
hosts of MAYV.
Madariaga virus is the new designation for the South
American isolates of eastern equine encephalitis virus.21 In
South America, this virus has caused equine encephalitis
outbreaks, but only two human caseswere detected to date
(in Brazil and Trinidad).6 The low MADV seroprevalence
observed in this study corroborates a previous study in
Iquitos that showed a seroprevalence of 3% (9/359).6 This
result is in contrast to the high human seroprevalence and
cases reported in Panama.8 Cross-protective antibodies
may be one of the factors limiting the infection and disease
in South America.6 Although the virus was isolated from
Culex mosquitoes in areas near Iquitos, our study found
only one seropositive individual, a 45-year-old male hunter
and logger who also showed exposure to MAYV.11 Evi-
dence of exposure to only MADV is unusual: most sero-
positive individuals also show exposure to MAYV, VEEV, or
UNAV.6
TABLE 1
Characteristics of PRNT– positive individuals (n = 40) and laboratory findings*
Sample ID Gender Age (years) Hunter Logger House
Mayaro virus Madariaga virus
Venezuelan equine
encephalitis complex virus Una virus
PRNT PRNT titer ELISA PRNT PRNT titer ELISA PRNT PRNT titer ELISA Screen PRNT PRNT PRNT titer
MIS0963 F 21 No No A − − − − − + + 20 + − − −
MIS0965 F 35 No No A + 20 + NP NP NP NP NP NP NP NP NP
MIS0967 M 41 Yes Yes A − − + − − + − − − + + 20
MIS0968 F 33 No No A + 40 + − − NP − − NP NP NP NP
MIS0969 M 8 No No A + 40 + − − NP − − NP NP NP NP
MIS0972 M 7 No No D − − + − − + + 80 − − − −
MIS0974 M 67 Yes No E − − + − − − − − − + + 80
MIS0975 F 64 No No E + 160 + − − + − − − NP NP NP
MIS0977 M 29 No Yes F − − + − − NP + 80 NP NP NP NP
MIS0980 M 81 Yes No F + 160 + − − − − − − + + 80
MIS0983 M 70 Yes No G + 40 + − − −− − − − + + 40
MIS0985 M 33 No Yes H + 20 + − − + − − − NP NP NP
MIS0986 M 30 Yes No H + 40 + NP NP NP NP NP NP NP NP NP
MIS0988 M 39 Yes Yes I + 20 + − − NP − − NP NP NP NP
MIS0990 F 32 No No J − − − − − − − − − + + 40
MIS0991 F 26 No No K − − + − − + + 120 − NP NP NP
MIS0992 M 10 No No K + 40 + − − NP − − NP NP NP NP
MIS0994 F 20 No No L − − + − − − − − − − − −
MIS0995 M 45 Yes Yes L + 40 + + 40 NP − − NP NP NP NP
MIS1000 F 31 No No M − − + − − + + 40 + + + 80
MIS1001 F 6 No No M − − + − − − − − − − − −
MIS1004 F 25 No No N − − + − − − − − − − − −
MIS1006 M 52 Yes Yes N + 40 + − − NP − − NP NP NP NP
MIS1007 M 46 Yes Yes N + 20 + − − NP − − NP NP NP NP
MIS1008 F 13 No No O − − + − − − + 160 + − − −
MIS1011 M 30 Yes Yes Q − − + − − + − − − NP NP NP
MIS1013 M 13 No No R − − + − − − − − − − − −
MIS1014 M 10 No No S − − + − − + + 40 + − − −
MIS1018 F 7 No No T − − + − − − − − − − − −
MIS1021 M 18 Yes No U − − + NP NP NP NP NP NP NP NP NP
MIS1022 M 47 No Yes U + 20 + − − NP − − NP NP NP NP
MIS1023 M 74 Yes No U + 20 + − − NP − − NP NP NP NP
MIS1024 M 67 Yes No Z + 40 + − − − + 40 + − − −
MIS1025 F 8 No No Z − − + − − + + 80 + − − −
MIS1026 F 20 No No Z − − + − − + + 80 + NP NP NP
MIS1028 M 20 No No Z − − + − − + − − − − − −
MIS1029 F 17 No No NA + 20 + − − NP − − NP NP NP NP
MIS1030 F 6 No No NA − − + − − − − − − − − −
MIS1031 F 12 No No NA − − + − − − − − − − − −
MIS1032 F 35 No No NA − − + − − + + 40 − NP NP NP
M = males; F = females; NA = data not available; NP = not performed because of insufficient sample; PRNT = plaque reduction neutralization test.
* Each letter represents a house.
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Venezuelan equine encephalitis complex viruses such as
VEEV are known to cause human disease in the Peruvian
Amazon. The most recent VEEV outbreak caused by the
enzootic Panama/Peru ID genotype in Iquitos, in early 2006,
accounted for 63 cases and one fatality.4,5 In contrast, a
higher fatality rate was reported in Panama (5%, two deaths
from 39 cases studied). Different factors may be associated
with this difference: a more active surveillance in Panama
during outbreaks, underreporting of VEEV cases in Peru, or
other factors involved in the emergence of the enzootic
VEEV (virus adaptation to mosquito species or mosquito
abundance).22 In this study, the vaccine strain TC-83,
closely related to subtype ID, was used for the PRNT. Un-
fortunately, PRNTs were not performed using other VEE
complex viruses that are geographically relevant, limiting
our ability to definitively state which VEE complex virus was
involved in these cases. Interestingly, the VEE complex vi-
rus titers are low, presumably because of the infection with
sympatric alphaviruses inducing PRNT cross-reaction.
However, antibody titers waning over time is also a possi-
bility, as most of the VEE complex virus positives are in
older age.
Mayaro infections have been principally recognized dur-
ing outbreaks in South America; however, risk factors for the
infection and the clinical spectrum of MAYV infections are
poorly understood.1,23–26 The high seroprevalence (24%)
found in our study corroborates previous studies in indig-
enous groups of the Brazilian Amazon, where MAYV sero-
prevalence ranged from 20% to 47%, with an overall of 42%
for all the groups together.27 A greater seroprevalence was
also found in ethnic groups of French Guiana living in contact
with the forest comparedwith thosewhodo not.28 Despite the
growing concern of MAYV as an emerging virus that may
potentially spread and cause human outbreaks in theWestern
Hemisphere, less is known about the virus ecology.29 Most
evidence comes from Brazilian studies, which proposed
FIGURE 2. Complete (A) and final (B) classification trees exploring
the influence of gender and hunting or logging behaviors on the
probability of showing antibodies againstMayaro virus in the Peruvian
Amazon forest. The factor “cohabit” indicatespeoplewhoshare home
with a Mayaro seropositive person. Note that gender was initially
retained but later excluded after model simplification. Left branches
indicate no hunters or no cohabitation, whereas the right branches
summarize the probability for male hunters or cohabiting people.
TABLE 2
Mayaro virus seroprevalence in wild animals hunted by Nueva Esperanza and Sol Naciente communities in the northeastern Peruvian
Amazon
Group Common name Scientific name No. PRNT positive (%)*
Mammals Edentate Nine-banded armadillo Dasypus novemcinctus 2/4 (50.0)
Three-toed sloth Bradypus sp. 0/1 (0.0)
Subtotal 2/5 (40)
Primate Poeppig’s woolly monkey Lagothrix poeppigii 6/11 (54.5)
Red howler monkey Alouatta seniculus 1/1 (100.0)
Red uakari Cacajao calvus 1/3 (33.3)
Large-headed capuchin Sapajus macrocephalus 1/6 (16.7)
Squirrel monkey Saimiri macrodon 0/3 (0.0)
White-fronted capuchin Cebus albifrons 0/2 (0.0)
Monk saki Pithecia monachus 0/1 (0.0)
Subtotal 9/27 (33)
Artiodactyla Collared peccary Pecari tajacu 1/6 (16.7)
Red brocket deer Mazama americana 0/3 (0.0)
Subtotal 1/9 (11)
Rodent Wild black agouti Dasyprocta fuliginosa 3/27 (11.1)
Lowland paca Cuniculus paca 1/10 (10.0)
Northern Amazon red squirrel Sciurus igniventris 0/1 (0.0)
Spiny rat Proechimys sp. 0/1 (0.0)
Subtotal 4/39 (10)
Carnivora South American coati Nasua nasua 0/4 (0.0)
Subtotal 0/4 (0)
Subtotal 16/84 (19)
Birds Blue-and-yellow macaw Ara ararauna 0/2 (0.0)
Great tinamou Tinamus major 0/2 (0.0)
Rufescent tiger heron Tigrisoma lineatum 0/1 (0.0)
Speckled chachalaca Ortalis guttata 0/1 (0.0)
Subtotal 0/6 (0)
Total 16/90 (18)
PRNT = plaque reduction neutralization test.
* Samples were first tested with an ELISA for the presence of Mayaro virus antibodies, and in those screening positive, a confirmatory PRNT was performed.
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nonhumanprimates as themost important amplifying hosts.23
The virus was isolated from a marmoset (Callithrix sp.) cap-
tured during an MAYV outbreak in Brazil, and experimental
infections in these animals confirmed the occurrence of vire-
mia post-MAYV infection.23 The virus was also isolated from
only one migrating bird (Icterus spurius) from a total of 1,300
birds studied in the United States in 1967.30 Serologic studies
foundMAYVantibodies in other sylvatic vertebrates andbirds,
but their exact role in the transmission of the virus is not
determined.31–33 This study detected anti–MAYV-neutralizing
antibodies in wild animal species, which are consistent with
previously described epidemiologic patterns of the sylvatic
cycle,where arboreal anddiurnalwild animalsweremore likely
to be infected.32 Nevertheless, other terrestrial and nocturnal
species were also seropositive in our study. Similar to our
findings, previous studies indicated that nonhuman primates
had high MAYV seropositive rates, presumably reflecting
these animals’ preference for a lower to mid-canopy habitat,
where potential vectors are often present.23,32 We also found
seropositive rodents and marsupials, possibly infected by
Haemagogus janthinomys mosquitoes, known enzootic vec-
tor of MAYV that reside in upper and lower canopy in the
Peruvian Amazon.34 These mosquitoes are daytime feeders,
which may explain why hunting was a risk factor. This result
corroborates a previous study in the Amazon rainforest of
Ecuador, where the high seroprevalence detected in the
Amazon-native personnel of the Ecuadorian armed forces
was associated with hunting.14 The higher MAYV risk due to
cohabitation may suggest the presence of infected dwelling
species, opening up the possibility for a human–mosquito–
human transmission cycle. Although H. janthinomys is re-
ported to have a low activity near houses in the Amazon
rainforest, the lack of MAYV isolation from other mosquito
species and vector competence studies are unable to
confirm a human-mosquito-human transmission.23,35 Mayaro
virus has been isolated from Aedes (Ochlerotatus) serratus,
Psorophora ferox,Psorophoraalbipes, andCulexspp.captured
indoor and outdoor in a village in the Iquitos region and at the
forest area.36 Evaluating the capacity of these species to
transmit the virus is highly relevant. Urban-adapted species
such as Aedes aegypti and Aedes albopictus, known vectors
of other human arboviruses (e.g., dengue and chikungunya) in
Iquitos, are proved competent MAYV vectors in laboratory
conditions. However, other species, for example, Anopheles
spp., may also be important vectors that sustain the trans-
mission of MAYV.35,37
Here, we also demonstrate the highest observed human
prevalence of UNAV reported to date in Latin America. Low
UNAV prevalence was previously reported in Iquitos and peri-
urban and urban areas in Argentina and Paraguay where it is
less likely to be in contact with the enzootic cycle.6,12,38 Our
results show that hunting was a main risk factor for UNAV
infection, and this suggests that introduction into the forest
potentially increases the contact with humans and the trans-
mission cycle. Ecological evidence suggests that Ae.
(Ochlerotatus) fulvus,P. ferox, andPsorophora albigenumight
be themosquito species involved in the enzootic circulation of
UNAV, which is principally distributed in sylvatic areas of Latin
American countries.11
Although disease severity varies between individuals, the
chronic debilitating joint pain associated with Mayaro fever
may severely impair the livelihoods of MAYV-infected people,
whereas VEEV may cause fatal encephalitis.1 Unfortunately,
no medical history was available to associate the seroposi-
tivity with the presence of chronic arthralgia or neurologic
disease.
Although wild animals may have contributed to the am-
plification of MAYV during past Amazonian outbreaks,
reservoir hosts for MADV, UNAV, and VEE complex alpha-
viruses in the Peruvian Amazon remain unknown.23 We also
do not rule out the possibility that some MAYV seropositive
animal samples could be due to a cross-reaction with UNAV;
however, this hypothesis could not be tested because of
insufficient samples. In humans, we found antibodies against
both MAYV and UNAV in two individuals, but most MAYV
seropositives were not tested for UNAV. The sample limita-
tion did not allowus to indicate a reliable proportion ofMAYV/
UNAV cross-reactions. It is unclear whether the cross-
neutralizing patterns shown in these two individuals are due
to cross-reaction among these viruses or real independent
infections. Future studies should evaluate this possibility in a
prospective follow-up of patients.
The cross-sectional nature of the study design does not allow
us to draw a conclusion of temporal association between the
exposure to the virus and infection. However, our study was
designed to explore potential factors of alphavirus infection and
not to test hypothesis-driven questions. As sympatric alphavi-
ruses circulate in the Amazon region of Peru, it is possible to
observe cross-reaction among members of the genus
Alphavirus.8,39 However, we used PRNT, which is the gold
standard for alphavirusdiagnosisandprovidesahighlyaccurate
classification among members of the same antigenic complex.
In summary, we provide the first evidence of human
alphavirus infection in an indigenous community from the
Peruvian Amazon. Our results also suggest that sympatric
human alphavirus infections are common in the Amazon re-
gion of Peru.
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